Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
Titel:
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
Auteur:
Lawitz, Eric Lalezari, Jay P Hassanein, Tarek Kowdley, Kris V Poordad, Fred F Sheikh, Aasim M Afdhal, Nezam H Bernstein, David E DeJesus, Edwin Freilich, Bradley Nelson, David R Dieterich, Douglas T Jacobson, Ira M Jensen, Donald Abrams, Gary A Darling, Jama M Rodriguez-Torres, Maribel Reddy, K Rajender Sulkowski, Mark S Bzowej, Natalie H Hyland, Robert H Mo, Hongmei Lin, Ming Mader, Michael Hindes, Robert Albanis, Efsevia Symonds, William T Berrey, Michelle M Muir, Andrew